Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Industry Roundup: Cardinal Buys Harvard Drug, Similac Lawsuit, State AGs Question Supplement Oversight

This article was originally published in The Tan Sheet

Executive Summary

Cardinal acquires Harvard Drug; Similac ‘organic’ claims deceptive – complaint; N.Y., Ind. criticize supplement regulatory flexibility; Amway headquarters manufacturing site opens; and more news in brief.

Advertisement

Related Content

Health And Wellness Industry Regulatory Roundup
PharmaTech Adds Supplements To Recall Nearly A Month After Drugs
Harvard Drug Continues Expansion With Watson’s Rugby OTC Business

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register